Implant Sciences Corporation develops, manufactures, and sells sensors and systems for the security, safety, and defense industries. The company has developed proprietary technologies used in explosives and narcotics trace detection (ETD and NTD, respectively) applications, and markets and sells handheld ETD and benchtop ETD and NTD systems that use its proprietary technologies. Its products are marketed and sold to various locations in the United States and internationally, such as India and France. These systems are used by private companies and government agencies to screen baggage, cargo, other objects and people for the detection of trace amounts of explosives and narcotics. Products The company has developed various explosives detection systems designed for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. The systems use its proprietary Quantum Sniffer technologies, including a photon-based, non-radioactive ion source in combination with ion mobility spectrometry (IMS), a classic detection tool sensitive to the speeds with which ions of various substances move through the air to electronically detect minute quantities of explosives vapor and particles. Quantum Sniffer QS-H150 Portable Explosives Detector The Quantum Sniffer QS-H150 Portable Explosives Detector employs a patented vortex collector for the detection of explosives particulates and vapors with or without physical contact and in real-time. The QS-H150 could detect vapors and nanogram quantities of explosives particulates for various explosives substances considered to be threats. Such substances include military and commercial explosives, improvised and homemade explosives, propellants, and taggants. The QS-H150 has automatic and continuous self-calibration. It monitors its environment, senses changes that would affect its accuracy, and re-calibrates accordingly. Quantum Sniffer QS-B220 Benchtop Explosives and Narcotics Detector The company’s new QS-B220 Benchtop Explosives and Narcotics Detector uses dual IMS with non-radioactive ionization for the detection and identification of a range of military, commercial, and improvised explosives, as well as narcotics. The QS-B220 uses a sample trap, which is wiped on the surface to be interrogated for explosives or narcotics particles. The QS-B220 has automatic and continuous self-calibration. It monitors its environment, senses changes that would affect its accuracy, and re-calibrates accordingly. For detection, the sample is collected with a standard trap, ionized, and analyzed using IMS technology. The presence of a threat is indicated by visible and audible alarms, and the substance is identified and displayed on the integrated touch screen display. Users might save data locally or send data through standard interfaces, such as USB and LAN. Multi-level password-protected data security is standard. The company offers the QS-B220 at the Force Protection Equipment Demonstration, sponsored by the Department of Defense and Department of Energy. The QS-B220 received a ‘Developmental Testing & Evaluation Designation’ from the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002. Products under Development Quantum Sniffer QS-H150E Portable Explosives and Narcotics Detector The company is developing a next-generation handheld detector that would use dual IMS non-radioactive ionization for the detection and identification of a range of military, commercial, and improvised explosives, as well as narcotics. The QS-H150E would have automatic and continuous self-calibration, multi-level password-protected data security and would include a data management interface with data export to a network for recordkeeping, providing a link with the central command centers and logistics systems used by major carriers. Miniature Mass Spectrometer The company developed its own proprietary IMS technology. It obtains miniaturized quadrupole mass spectrometry (QMS) detector technology. When used in conjunction with an IMS, the QMS detector senses the molecular weight of the chemical species resulting in an ‘orthogonal’ detection method in which a fundamental characteristic of a substance is measured. The company is developing interfaces for integrating the QMS detector into its future products. Hyphenated Detectors The company is developing hyphenated systems employing conventional ion mobility, differential mobility, and QMS. It has one patent issued in real-time trace detection by IMS and QMS, and two hyphenated system patents pending. These methods focus on real-time detection, identification and analysis of trace amounts of narcotics, explosives and chemical agents. Marketing and Sales The company markets and sells its products through direct sales and marketing staff located in the United States, in addition to a global network of independent and specialized sales representatives and distributors. Growth Strategy The company’s growth strategy is to focus on penetrating the U.S. market through the transportation security administration ‘qualification’ and the retention of major industry advisors; to capitalize on its expanded sales and marketing capabilities to drive and support sales growth in its international markets; and to utilize its core intellectual property to extend its product offerings and through licensing or joint development agreements. Research and Development The company spent approximately $4,754,000 on internally funded research and development in the year ended June 30, 2013. Intellectual Property The company’s intellectual portfolio contains 22 security-related patents and patents pending, including 15 patents have been issued and are active, 5 patents are pending, and the company licenses 2 patents. The 15 issued patents expire in the years 2022 through 2033. Competition The company’s major competitors include Morpho Detection, Inc.; Smiths Detection, Inc.; and NucTech Company Limited. History Implant Sciences Corporation was founded in 1984. The company was incorporated in 1984.
implant sciences corp (IMSC:OTC US)
500 Research Drive
Wilmington, MA 01887
|Price/Cash Flow||NM||Not Meaningful|
Post a JobJobs
- New York City, NY | Deepa GurnaniPosted: Apr 15
- San Francisco, CA | SmartrecruitersPosted: Apr 09
- Washington, DC | DC BarPosted: Apr 09
- Washington, DC | DC BarPosted: Apr 09
Sponsored Financial Commentaries
To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.